Introduction
Platelet factor-4 (PF4) is a protein released from activated platelets that plays a role in blood clotting, inflammation, and wound healing. It binds to heparin and neutralizes its anti-clotting effects. PF4 also attracts immune cells like neutrophils and fibroblasts to injury sites. Recombinant human PF4 is used in research to study heparin-induced thrombocytopenia, angiogenesis inhibition, and other related processes.
Description
Recombinant human PF4 is a non-glycosylated protein with a molecular weight of 10 kDa. It consists of a single polypeptide chain of 91 amino acids (residues 32-101) and includes a 21 amino acid His-tag at the N-terminus for purification. The protein is produced in E. coli and purified using chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The PF4 protein solution is provided at a concentration of 0.25 mg/ml in a buffer containing 20mM Tris-HCl (pH 8.0), 0.2M NaCl, 50% glycerol, and 2mM DTT.
Stability
For short-term storage (up to 4 weeks), store the PF4 protein at 4°C. For long-term storage, freeze the protein at -20°C. Adding a carrier protein such as 0.1% HSA or BSA is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of the PF4 protein is greater than 85% as determined by SDS-PAGE analysis.
Synonyms
CXCL4, PF-4, PF4, Iroplact, Oncostatin-A, SCYB4, MGC138298.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MEAEEDGDLQ CLCVKTTSQV RPRHITSLEV IKAGPHCPTA QLIATLKNGR KICLDLQAPL YKKIIKKLLE S.